Should I invest in ICICI Prudential Nifty Pharma Index Fund?

We don't give personal investment advice. ICICI Prudential Nifty Pharma Index Fund - Growth is suitable for an investor whose:understands what asset class this scheme actually invests in (check the factsheet)matches that asset class's volatility profile to their goal horizonCross-check the numbers above against alternatives before deciding.

ICICI Prudential

ICICI Prudential Nifty Pharma Index Fund - Growth

Latest NAV

₹18.2110

As of

3 Jun 2026

851 NAV records on file

NAV history & peer comparison

All NAVs split-adjusted and normalised to 100 at the start of the selected period, so funds with very different absolute NAV scales can be compared on one axis.

Period

Add another fund to compare

No matches.

Compares up to 8 funds. Click any line in the legend above to hide/show it.

Returns matrix

Fund return alongside the category average and peer rank for every standard window. Returns under one year are absolute; one year and longer are compound annualised (CAGR).

Window	Fund	Category avg	+/− vs avg	Rank	Quartile
1D	-0.86%	+0.28%	-1.14	70 / 70	Q4
1W	-2.64%	-1.03%	-1.61	65 / 66	Q4
2W	-3.48%	+0.07%	-3.55	63 / 64	Q4
1M	+2.18%	-0.94%	+3.13	3 / 62	Q1
3M	+4.26%	-1.73%	+5.99	4 / 62	Q1
6M	+4.46%	-4.34%	+8.80	3 / 62	Q1
YTD	+5.80%	-4.82%	+10.62	2 / 61	Q1
1Y	+11.75%	+0.34%	+11.41	4 / 61	Q1
2Y	+12.27%	+3.20%	+9.07	2 / 54	Q1
3Y	+22.18%	+10.47%	+11.71	2 / 52	Q1
4Y	—	—	—	—	—
5Y	—	—	—	—	—
7Y	—	—	—	—	—
10Y	—	—	—	—	—
Inception	+18.97%	+7.72%	+11.25	5 / 70	Q1

Quartile legend: Q1 top 25% Q2 25-50% Q3 50-75% Q4 bottom 25%

Calendar-year returns

Full-year performance vs category average. Current year is partial (year-to-date).

Year	Fund	Category avg	+/− vs avg	Rank
2026 YTD	+5.80%	-4.82%	+10.62	2 / 61
2025	-3.36%	+7.96%	-11.32	53 / 57
2024	+37.77%	+12.60%	+25.17	1 / 52
2023	+32.63%	+21.36%	+11.27	6 / 46
2022	—	—	—	—

Rolling returns

Removes start-date bias by averaging CAGR over every overlapping N-year window in the fund's history. Higher average plus tight min/max plus high "% positive" = consistent.

1-Year rolling

+22.88%

31 windows

min -6.0% · max 60.1%

84% positive

Limited basis — fund is young, so this average may be skewed by which 1Y windows happen to be available.

3-Year rolling

+21.51%

6 windows

min 20.0% · max 23.3%

100% positive

Limited basis — fund is young, so this average may be skewed by which 3Y windows happen to be available.

5-Year rolling

—

Insufficient history

7-Year rolling

—

Insufficient history

SIP returns — historical "what if"

If you had invested every month in this fund over the chosen period, this is what your investment would be worth today.

Period

Total invested

₹ —

Today's value

₹ —

XIRR

Annualised

Wealth multiplier

Period	Total invested	Today's value	XIRR	Wealth multiplier

XIRR is the annualised internal rate of return on the SIP cash flow — invariant to the monthly amount. "Today's value" and "Total invested" scale linearly with the slider. Past performance does not guarantee future returns. Excludes exit load and taxes.

Risk profile

Risk-adjusted return and volatility, computed from monthly NAV returns over the trailing 3-year and 5-year windows.

Std deviation

15.81%

3-year · annualised

Sharpe ratio

0.95

vs risk-free 6.5%

Sortino ratio

1.77

Downside-only deviation

Max drawdown

-16.78%

Oct 2024 → Feb 2025

% positive months

61.1%

Share of monthly returns > 0 over the 3-year window

Sharpe / Sortino use a risk-free rate of 6.5% (1-year T-bill proxy). Higher Sharpe = more return per unit of total risk; higher Sortino = more return per unit of downside risk.

Peers in Index Fund

Scheme	Fund house	NAV	As of
HDFC Nifty India Consumption Index Fund - Regular Growth Plan	HDFC	₹9.3253	3 Jun 2026
Nippon India Nifty Auto Index Fund - Direct Plan- Growth Option	Nippon India	₹11.1424	3 Jun 2026
SBI BSE PSU BANK INDEX FUND- Direct Plan- Growth	SBI	₹13.2031	3 Jun 2026
ICICI Prudential Nifty Auto Index Fund - Direct Plan - Growth	ICICI Prudential	₹20.9958	3 Jun 2026
Invesco India Nifty Bank Index Fund - Direct Plan - Growth	Invesco	₹9.9747	3 Jun 2026
Bandhan BSE Healthcare Index Fund Direct Plan - Growth	Bandhan	₹10.7220	3 Jun 2026
Aditya Birla Sun Life BSE India Infrastructure Index Fund-Direct Growth	Aditya Birla Sun Life	₹9.5100	3 Jun 2026
Motilal Oswal BSE Financials ex Bank 30 Index Fund Direct Growth	Motilal Oswal	₹16.4405	3 Jun 2026
Kotak BSE Housing Index Fund - Regular Plan - Growth Option	Kotak	₹12.2530	3 Jun 2026
DSP Nifty Bank Index Fund - Direct - Growth	DSP	₹11.1324	3 Jun 2026

Recent NAVs

Date	NAV
3 Jun 2026	₹18.2110
2 Jun 2026	₹18.1509
1 Jun 2026	₹18.3080
29 May 2026	₹18.4089
27 May 2026	₹18.6859
26 May 2026	₹18.6436
25 May 2026	₹18.6559
22 May 2026	₹18.5815
21 May 2026	₹18.8218
20 May 2026	₹18.7866

Frequently asked questions

These answers are generated from this fund's live metrics — NAV, returns, peer rank, drawdown, SIP backtest. Numbers refresh nightly after AMFI's NAV feed lands.

As of 03 Jun 2026, the NAV of ICICI Prudential Nifty Pharma Index Fund - Growth is ₹18.2110. It's a Index Fund from ICICI Prudential, run as a Unknown plan Growth option. NAVs update once per business day from the AMFI feed.

ICICI Prudential Nifty Pharma Index Fund - Growth has NAV history starting from 15 Dec 2022, a track record of about 3 years 5 months. It's a relatively new scheme. With under 5 years of NAVs, peer comparison is the best yardstick — point-to-point returns can be skewed by entry timing.

ICICI Prudential Nifty Pharma Index Fund - Growth is managed by ICICI Prudential. It's classified by AMFI under the 'Index Fund' SEBI category, which determines its peer set and tax treatment.

Over the trailing 1-year window, ICICI Prudential Nifty Pharma Index Fund - Growth has delivered a absolute return of 11.75% — +11.41 pp ahead of the Index Fund category average of 0.34%. The fund ranks #4 of 61 in its category — the top (Q1) quartile.

Over the trailing 3-year window, ICICI Prudential Nifty Pharma Index Fund - Growth has delivered a CAGR of 22.18% — +11.71 pp ahead of the Index Fund category average of 10.47%. The fund ranks #2 of 52 in its category — the top (Q1) quartile.

ICICI Prudential Nifty Pharma Index Fund - Growth doesn't have a complete 5-year window yet (we need at least 5 year of NAVs). Check the shorter-window returns above.

₹1 lakh invested in ICICI Prudential Nifty Pharma Index Fund - Growth exactly 3 years ago would be worth approximately ₹182,392 today — a multiplier of 1.82×, based on the 3-year CAGR of 22.18%. The category average over the same window would have grown ₹1 lakh to ₹134,808.

A ₹10,000 monthly SIP in ICICI Prudential Nifty Pharma Index Fund - Growth over the last 3 years — total invested ₹360,000 — would be worth ₹439,463 today. That's an XIRR (money-weighted annualised return) of 13.38%.

ICICI Prudential Nifty Pharma Index Fund - Growth doesn't yet have 10 years of NAVs. Over the longest available window (3-year SIP), ₹10,000/month would have grown to ₹439,463 — XIRR 13.38%.

On a 3-year basis, ICICI Prudential Nifty Pharma Index Fund - Growth ranks #2 out of 52 funds in the Index Fund category — that places it in the top quartile (Q1) — strong outperformance. The category average return over the same window is 10.47%; this fund delivered 22.18%.

The worst peak-to-trough decline ICICI Prudential Nifty Pharma Index Fund - Growth has experienced over the last 3-year window is 16.78% — its NAV fell from a high on 09 Oct 2024 to a low on 28 Feb 2025. Drawdown is a useful gauge of how much short-term pain you'd have endured to capture the long-term return.

Across all 3-year rolling windows, ICICI Prudential Nifty Pharma Index Fund - Growth averaged 21.51% (best 23.31%, worst 19.99%). 100% of rolling windows ended positive. The 3-year Sharpe ratio is 0.94 — reasonable risk-adjusted performance.

In calendar year 2025, ICICI Prudential Nifty Pharma Index Fund - Growth returned -3.36% — lagging the Index Fund category average of 7.96% by 11.32 pp. It ranked #53 of 57 in its category that year.

ICICI Prudential Nifty Pharma Index Fund - Growth doesn't fit cleanly into the standard Equity/Debt buckets in our taxonomy. Tax treatment depends on actual asset allocation as disclosed by the AMC — check the factsheet or AMFI's classification table.

We don't give personal investment advice. ICICI Prudential Nifty Pharma Index Fund - Growth is suitable for an investor whose:

understands what asset class this scheme actually invests in (check the factsheet)
matches that asset class's volatility profile to their goal horizon

Cross-check the numbers above against alternatives before deciding.

Educational content only — not investment advice. Tax rules summarised above reflect Budget 2024; consult a qualified adviser before transacting.